Lannett Co Inc (LCI)
(Delayed Data from NYSE)
$8.54 USD
+0.70 (8.93%)
Updated May 3, 2019 04:00 PM ET
After-Market: $8.54 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
[LCI]
Reports for Purchase
Showing records 1 - 20 ( 421 total )
Industry: Medical - Drugs
Industry: Medical - Drugs
FY2Q23 Recap - Solid Results; Insulin Data on Deck
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
FY4Q22 Recap - Challenging Environment; Focus on Insulin
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
Industry: Medical - Drugs
FY3Q22 Recap - Challenging Environment Persists
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
Industry: Medical - Drugs
FY2Q22 Recap - Challenging, But Pipeline Progress
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
Industry: Medical - Drugs
FY1Q22 Recap - Challenging Environment Continues
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
FY4Q21 Recap - Challenging Environment; Pipeline Coming in FY2023
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S